Both perform and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease

51Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fas ligand (Fast) and perform pathways not only are the major mechanisms of T cell-mediated cytotoxicity but also are involved in homeostatic regulation of these T cells. In the present study, we tested whether CD8+ donor T cells that are deficient in both perform and FasL (cytotoxic double deficient [cdd]) could induce graft-versus-host disease (GVHD) in a major histocompatibility complex class I-mismatched lethally irradiated murine model. Interestingly, recipients of cdd CD8+ T cells demonstrated significantly greater serum levels of interferon gamma and tumor necrosis factor alpha and histopathologic damage from GVHD than wild-type (wt) T cells on day 30 after allogeneic bone marrow transplantation (P

Cite

CITATION STYLE

APA

Maeda, Y., Levy, R. B., Reddy, P., Liu, C., Clouthier, S. G., Teshima, T., & Ferrara, J. L. M. (2005). Both perform and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood, 105(5), 2023–2027. https://doi.org/10.1182/blood-2004-08-3036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free